ID: ALA4527678

Max Phase: Preclinical

Molecular Formula: C18H30N4O10

Molecular Weight: 462.46

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@H]1C[C@H](OCCN=[N+]=[N-])[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@@H]2O)C[C@@H]1C(=O)OC

Standard InChI:  InChI=1S/C18H30N4O10/c1-28-16(26)8-5-10(30-4-3-21-22-20)11(6-9(8)17(27)29-2)31-18-15(25)14(24)13(23)12(7-19)32-18/h8-15,18,23-25H,3-7,19H2,1-2H3/t8-,9-,10-,11-,12+,13+,14-,15-,18-/m0/s1

Standard InChI Key:  FXXRFMDOYRBMNI-JRFCXQANSA-N

Associated Targets(Human)

CD209 antigen 101 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 462.46Molecular Weight (Monoisotopic): 462.1962AlogP: -1.79#Rotatable Bonds: 9
Polar Surface Area: 215.76Molecular Species: ZWITTERIONHBA: 12HBD: 4
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: -10.22CX Basic pKa: 8.80CX LogP: -2.16CX LogD: -3.68
Aromatic Rings: 0Heavy Atoms: 32QED Weighted: 0.10Np Likeness Score: 1.26

References

1. Valverde P, Ardá A, Reichardt NC, Jiménez-Barbero J, Gimeno A..  (2019)  Glycans in drug discovery.,  10  (10): [PMID:31814952] [10.1039/C9MD00292H]

Source